156 related articles for article (PubMed ID: 36913166)
1. Two-year outcomes of patients presenting to Sydney Eye Hospital with neovascular glaucoma.
Kingston EJ; Lusthaus JA
Int Ophthalmol; 2023 Aug; 43(8):2763-2776. PubMed ID: 36913166
[TBL] [Abstract][Full Text] [Related]
2. Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.
Tatsumi T; Yamamoto S; Uehara J; Sugawara T; Baba T; Inoue M; Hata H; Mitamura Y
Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1355-60. PubMed ID: 23250484
[TBL] [Abstract][Full Text] [Related]
3. A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L; Cușnir V; Bobescu D
Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
5. Visual Outcomes in Eyes With Neovascular Glaucoma and Anterior Segment Neovascularization Without Glaucoma.
Sastry A; Ryu C; Jiang X; Ameri H
Am J Ophthalmol; 2022 Apr; 236():1-11. PubMed ID: 34562418
[TBL] [Abstract][Full Text] [Related]
6. Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.
Kiuchi Y; Nakae K; Saito Y; Ito S; Ito N
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1627-32. PubMed ID: 16639623
[TBL] [Abstract][Full Text] [Related]
7. Trabeculectomy for neovascular glaucoma in proliferative diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome: Surgical outcomes and prognostic factors for failure.
Senthil S; Chary R; Ali MH; Cherukuri JR; Rani PK; Krishnamurthy R; Choudhari N; Garudadri C
Indian J Ophthalmol; 2021 Nov; 69(11):3341-3348. PubMed ID: 34708802
[TBL] [Abstract][Full Text] [Related]
8. Management and Systemic Implications of Diabetic Neovascular Glaucoma.
Sánchez-Tabernero S; Juberías JR; Artells N; Crespo-Millas S; Meneses C; Muñoz-Moreno MF; Manzanas L; López Gálvez MI
Ophthalmic Res; 2019; 62(2):111-115. PubMed ID: 31167215
[TBL] [Abstract][Full Text] [Related]
9. Bevacizumab as adjuvant for neovascular glaucoma.
Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S
Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
[TBL] [Abstract][Full Text] [Related]
10. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term.
Sun Y; Liang Y; Zhou P; Wu H; Hou X; Ren Z; Li X; Zhao M
BMC Ophthalmol; 2016 Aug; 16(1):150. PubMed ID: 27576739
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma.
Ciftci S; Sakalar YB; Unlu K; Keklikci U; Caca I; Dogan E
Eur J Ophthalmol; 2009; 19(6):1028-33. PubMed ID: 19882572
[TBL] [Abstract][Full Text] [Related]
12. Visual prognosis and surgical timing of Ahmed glaucoma valve implantation for neovascular glaucoma secondary to diabetic vitrectomy.
Lee JS; Lee YB; Kim TW; Park KH
BMC Ophthalmol; 2023 Mar; 23(1):107. PubMed ID: 36932350
[TBL] [Abstract][Full Text] [Related]
13. Anti-vascular endothelial growth factor for neovascular glaucoma.
Simha A; Aziz K; Braganza A; Abraham L; Samuel P; Lindsley KB
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD007920. PubMed ID: 32027392
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience in the management of neovascular glaucoma.
Kuang TM; Liu CJ; Chou CK; Hsu WM
J Chin Med Assoc; 2004 Mar; 67(3):131-5. PubMed ID: 15181965
[TBL] [Abstract][Full Text] [Related]
15. Full preoperative panretinal photocoagulation improves the outcome of trabeculectomy with mitomycin C for neovascular glaucoma.
Al Obeidan SA; Osman EA; Al-Amro SA; Kangave D; Abu El-Asrar AM
Eur J Ophthalmol; 2008; 18(5):758-64. PubMed ID: 18850555
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of neovascular glaucoma in eyes presenting with moderate to good visual potential.
Rani PK; Sen P; Sahoo NK; Senthil S; Chakurkar R; Anup M; Behera UC; Sivaprasad S; Das T;
Int Ophthalmol; 2021 Jul; 41(7):2359-2368. PubMed ID: 33745037
[TBL] [Abstract][Full Text] [Related]
17. Circumpapillary retinal nerve fiber layer thickness, anterior lamina cribrosa depth, and lamina cribrosa thickness in neovascular glaucoma secondary to proliferative diabetic retinopathy: a cross-sectional study.
Yokota S; Takihara Y; Takamura Y; Inatani M
BMC Ophthalmol; 2017 Apr; 17(1):57. PubMed ID: 28446148
[TBL] [Abstract][Full Text] [Related]
18. Anti-vascular endothelial growth factor for neovascular glaucoma.
Rittiphairoj T; Roberti G; Michelessi M
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007920. PubMed ID: 37010901
[TBL] [Abstract][Full Text] [Related]
19. [Profile of neovascular glaucoma in Senegalese patients].
Ndiaye-Sow MN; Seck SM; Dieng M; Diakhaté-Diouf M; Agboton GA; Gueye NN
J Fr Ophtalmol; 2018 Sep; 41(7):637-641. PubMed ID: 30166236
[TBL] [Abstract][Full Text] [Related]
20. Combined vitrectomy, near-confluent panretinal endolaser, bevacizumab and cyclophotocoagulation for neovascular glaucoma - a retrospective interventional case series.
Strzalkowski P; Strzalkowska A; Göbel W; Loewen NA; Hillenkamp J
F1000Res; 2020; 9():1236. PubMed ID: 33796275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
